Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02274311Phase 2Completed
Phase 2, open-label, single-arm trial of clomiphene in acromegaly. Primary endpoint: Serum Insulin Like Growth Factor 1 Levels at Day 90. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02274311.